Elaspeg 3750Iu Injection Substitute
by Others
by Others
by Others
by Others
by AYUR
by Others
by Others
Composition:
PEGASPARGASE-3750IU
Uses:
Elaspeg 3750Iu Injection is used in the treatment of Acute Lymphoblastic Leukaemia (ALL). The detailed use of Elaspeg 3750Iu Injection is as follows:<br/>• Treatment of Acute Lymphoblastic Leukaemia (ALL): Elaspeg 3750Iu Injection is used to treat acute lymphoblastic leukemia (ALL) by depleting asparagine, a crucial amino acid for cancer cell growth, ultimately killing or stopping the growth of these cells.<br/>
Medicinal Benefits:
Elaspeg 3750Iu Injection is used to treat acute lymphoblastic leukaemia (ALL). It is also used with other chemotherapy drugs to treat a certain type of ALL in people who have had allergic reactions to medications similar to pegaspargase, such as asparaginase. Elaspeg 3750Iu Injection contains Pegaspargase, an enzyme that breaks down asparagine, an important building block of proteins without which cells cannot survive. Normal cells can make asparagine for themselves, while some cancer cells cannot. Elaspeg 3750Iu Injection lowers asparagine levels in blood cancer cells and stops the cancer cells from growing.
Elaspeg 3750Iu Injection is used to treat Acute lymphoblastic leukaemia (ALL).
Elaspeg 3750Iu Injection works by killing or stopping the growth of cancer cells.
If anticoagulants are used at the same time as Elaspeg 3750Iu Injection, there may be a higher risk of bleeding disorders. Therefore, consult the doctor if you are taking anticoagulant/blood thinner medicines.
Oral contraceptive is not an effective method of contraception whilst on treatment with Elaspeg 3750Iu Injection. Ask your doctor about the best contraceptive to use.
Elaspeg 3750Iu Injection may cause osteonecrosis (bone damage), especially when taken concomitantly with glucocorticoids. If you experience any new bone pain, like pain in the hip, back or knee, inform the doctor as soon as possible.
Consult the doctor if you are undergoing immunisation with live vaccines within 3 months of completing the treatment, as it may increase the risk of severe infections.
Elaspeg 3750Iu Injection can lead to fluctuations in clotting factors and may increase the risk of bleeding and/or clotting. If you notice unusual bleeding or bruising, consult the doctor.